organization · Reporting owner

WAUD CAPITAL PARTNERS III, L.L.C.

Disclosed activity across 1 company

Tapewire entity: 182297
SEC CIK: 0001532461

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Acadia Healthcare Company, Inc.

Report date September 14, 2016 · Filed September 16, 2016

Jointly reported with WAUD CAPITAL PARTNERS MANAGEMENT III, L.P., WAUD CAPITAL PARTNERS III, L.P., WAUD CAPITAL PARTNERS QP III, L.P., WCP FIF III (ACADIA), L.P., WAUD CAPITAL AFFILIATES III, L.L.C.

Section 16 reporting ended · disclosed 2016-09-16. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, par value $0.01 per shareSEC Table I · non-derivative	IndirectSee footnotes	2,252,406	Reported balance After 2016-09-14 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2016-09-14 · Sale · Disposed 46,302 · Balance 2,252,406 F1: Represents shares sold in market transactions under Rule 144 as follows: (i) 1,154 shares by Waud Capital Partners III, L.P. ("WCP III"), (ii) 25,449 shares by Waud Capital Partners QP III, L.P. ("Waud QP III"), (iii) 14,397 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III") and (iv) 5,302 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"). F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4. F3: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners III, L.L.C. ("Waud III LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management III, L.P. ("WCPM III"). Waud III LLC is the general partner of WCPM III. WCPM III is the general partner of WCP III, Waud QP III and WCP FIF III and the manager of Waud Affiliates III. As a result, each of Mr. Waud, Waud III LLC and WCPM III may be deemed to share beneficial ownership of the reported shares. F8: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein.
Common Stock, par value $0.01 per shareSEC Table I · non-derivative	IndirectSee footnotes	2,128,933	Reported balance After 2016-09-15 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2016-09-15 · Sale · Disposed 123,473 · Balance 2,128,933 F4: Represents shares sold in market transactions under Rule 144 as follows: (i) 3,077 shares by WCP III, (ii) 67,867 shares by Waud QP III, (iii) 38,394 shares by WCP FIF III and (iv) 14,135 shares by Waud Affiliates III. F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4. F3: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners III, L.L.C. ("Waud III LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management III, L.P. ("WCPM III"). Waud III LLC is the general partner of WCPM III. WCPM III is the general partner of WCP III, Waud QP III and WCP FIF III and the manager of Waud Affiliates III. As a result, each of Mr. Waud, Waud III LLC and WCPM III may be deemed to share beneficial ownership of the reported shares. F8: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein.
Common Stock, par value $0.01 per shareSEC Table I · non-derivative	IndirectSee footnotes	1,841,265	Reported balance After 2016-09-16 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2016-09-16 · Sale · Disposed 287,668 · Balance 1,841,265 F6: Represents shares sold as follows: (i) 7,170 shares by WCP III, (ii) 158,116 shares by Waud QP III, (iii) 89,451 shares by WCP FIF III and (iv) 32,931 shares by Waud Affiliates III. F7: The reported shares are owned of record as follows: (i) 183,205 shares by WCP III, (ii) 1,036,001 shares by Waud QP III, (iii) 454,671 shares by WCP FIF III and (iv) 167,388 shares by Waud Affiliates III. F3: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners III, L.L.C. ("Waud III LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management III, L.P. ("WCPM III"). Waud III LLC is the general partner of WCPM III. WCPM III is the general partner of WCP III, Waud QP III and WCP FIF III and the manager of Waud Affiliates III. As a result, each of Mr. Waud, Waud III LLC and WCPM III may be deemed to share beneficial ownership of the reported shares. F8: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares sold in market transactions under Rule 144 as follows: (i) 1,154 shares by Waud Capital Partners III, L.P. ("WCP III"), (ii) 25,449 shares by Waud Capital Partners QP III, L.P. ("Waud QP III"), (iii) 14,397 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III") and (iv) 5,302 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III").

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4.

F3: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners III, L.L.C. ("Waud III LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management III, L.P. ("WCPM III"). Waud III LLC is the general partner of WCPM III. WCPM III is the general partner of WCP III, Waud QP III and WCP FIF III and the manager of Waud Affiliates III. As a result, each of Mr. Waud, Waud III LLC and WCPM III may be deemed to share beneficial ownership of the reported shares.

F4: Represents shares sold in market transactions under Rule 144 as follows: (i) 3,077 shares by WCP III, (ii) 67,867 shares by Waud QP III, (iii) 38,394 shares by WCP FIF III and (iv) 14,135 shares by Waud Affiliates III.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4.

F6: Represents shares sold as follows: (i) 7,170 shares by WCP III, (ii) 158,116 shares by Waud QP III, (iii) 89,451 shares by WCP FIF III and (iv) 32,931 shares by Waud Affiliates III.

F7: The reported shares are owned of record as follows: (i) 183,205 shares by WCP III, (ii) 1,036,001 shares by Waud QP III, (iii) 454,671 shares by WCP FIF III and (iv) 167,388 shares by Waud Affiliates III.

F8: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
September 16, 2016 Filed Sep 16, 2016 19:23 UTC	Acadia Healthcare Company, Inc. ACHC · Entity 4312	SaleCommon Stock, par value $0.01 per share	287,668	$47.74	$13,733,270.32	Disclosure SEC source: 0000899243-16-029177 · doc4.xml · nonDerivative · entry 3 WAUD CAPITAL PARTNERS III, L.L.C. · CIK 0001532461 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT III, L.P. · CIK 0001532462 · 10% owner WAUD CAPITAL PARTNERS III, L.P. · CIK 0001487016 · 10% owner WAUD CAPITAL PARTNERS QP III, L.P. · CIK 0001487019 · 10% owner WCP FIF III (ACADIA), L.P. · CIK 0001532465 · 10% owner WAUD CAPITAL AFFILIATES III, L.L.C. · CIK 0001532468 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,841,265 F6 · shares: Represents shares sold as follows: (i) 7,170 shares by WCP III, (ii) 158,116 shares by Waud QP III, (iii) 89,451 shares by WCP FIF III and (iv) 32,931 shares by Waud Affiliates III. F7 · balance_after: The reported shares are owned of record as follows: (i) 183,205 shares by WCP III, (ii) 1,036,001 shares by Waud QP III, (iii) 454,671 shares by WCP FIF III and (iv) 167,388 shares by Waud Affiliates III. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners III, L.L.C. ("Waud III LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management III, L.P. ("WCPM III"). Waud III LLC is the general partner of WCPM III. WCPM III is the general partner of WCP III, Waud QP III and WCP FIF III and the manager of Waud Affiliates III. As a result, each of Mr. Waud, Waud III LLC and WCPM III may be deemed to share beneficial ownership of the reported shares. F8 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document
September 15, 2016 Filed Sep 16, 2016 19:23 UTC	Acadia Healthcare Company, Inc. ACHC · Entity 4312	SaleCommon Stock, par value $0.01 per share	123,473	$49.24	$6,079,810.52	Disclosure SEC source: 0000899243-16-029177 · doc4.xml · nonDerivative · entry 2 WAUD CAPITAL PARTNERS III, L.L.C. · CIK 0001532461 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT III, L.P. · CIK 0001532462 · 10% owner WAUD CAPITAL PARTNERS III, L.P. · CIK 0001487016 · 10% owner WAUD CAPITAL PARTNERS QP III, L.P. · CIK 0001487019 · 10% owner WCP FIF III (ACADIA), L.P. · CIK 0001532465 · 10% owner WAUD CAPITAL AFFILIATES III, L.L.C. · CIK 0001532468 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 2,128,933 F4 · shares: Represents shares sold in market transactions under Rule 144 as follows: (i) 3,077 shares by WCP III, (ii) 67,867 shares by Waud QP III, (iii) 38,394 shares by WCP FIF III and (iv) 14,135 shares by Waud Affiliates III. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners III, L.L.C. ("Waud III LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management III, L.P. ("WCPM III"). Waud III LLC is the general partner of WCPM III. WCPM III is the general partner of WCP III, Waud QP III and WCP FIF III and the manager of Waud Affiliates III. As a result, each of Mr. Waud, Waud III LLC and WCPM III may be deemed to share beneficial ownership of the reported shares. F8 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document
September 14, 2016 Filed Sep 16, 2016 19:23 UTC	Acadia Healthcare Company, Inc. ACHC · Entity 4312	SaleCommon Stock, par value $0.01 per share	46,302	$50.19	$2,323,897.38	Disclosure SEC source: 0000899243-16-029177 · doc4.xml · nonDerivative · entry 1 WAUD CAPITAL PARTNERS III, L.L.C. · CIK 0001532461 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT III, L.P. · CIK 0001532462 · 10% owner WAUD CAPITAL PARTNERS III, L.P. · CIK 0001487016 · 10% owner WAUD CAPITAL PARTNERS QP III, L.P. · CIK 0001487019 · 10% owner WCP FIF III (ACADIA), L.P. · CIK 0001532465 · 10% owner WAUD CAPITAL AFFILIATES III, L.L.C. · CIK 0001532468 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 2,252,406 F1 · shares: Represents shares sold in market transactions under Rule 144 as follows: (i) 1,154 shares by Waud Capital Partners III, L.P. ("WCP III"), (ii) 25,449 shares by Waud Capital Partners QP III, L.P. ("Waud QP III"), (iii) 14,397 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III") and (iv) 5,302 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners III, L.L.C. ("Waud III LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management III, L.P. ("WCPM III"). Waud III LLC is the general partner of WCPM III. WCPM III is the general partner of WCP III, Waud QP III and WCP FIF III and the manager of Waud Affiliates III. As a result, each of Mr. Waud, Waud III LLC and WCPM III may be deemed to share beneficial ownership of the reported shares. F8 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document
September 13, 2016 Filed Sep 14, 2016 21:05 UTC	Acadia Healthcare Company, Inc. ACHC · Entity 4312	SaleCommon Stock, par value $0.01 per share	3,275	$51.23	$167,778.25	Disclosure SEC source: 0000899243-16-029008 · doc4.xml · nonDerivative · entry 2 WAUD CAPITAL PARTNERS III, L.L.C. · CIK 0001532461 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT III, L.P. · CIK 0001532462 · 10% owner WAUD CAPITAL PARTNERS III, L.P. · CIK 0001487016 · 10% owner WAUD CAPITAL PARTNERS QP III, L.P. · CIK 0001487019 · 10% owner WCP FIF III (ACADIA), L.P. · CIK 0001532465 · 10% owner WAUD CAPITAL AFFILIATES III, L.L.C. · CIK 0001532468 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 2,298,708 F4 · shares: Represents shares sold in market transactions under Rule 144 as follows: (i) 82 shares by WCP III, (ii) 1,800 shares by Waud QP III, (iii) 1,019 shares by WCP FIF III and (iv) 374 shares by Waud Affiliates III. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.15 to $51.85, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners III, L.L.C. ("Waud III LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management III, L.P. ("WCPM III"). Waud III LLC is the general partner of WCPM III. WCPM III is the general partner of WCP III, Waud QP III and WCP FIF III and the manager of Waud Affiliates III. As a result, each of Mr. Waud, Waud III LLC and WCPM III may be deemed to share beneficial ownership of the reported shares. F6 · ownership.nature: The reported shares are owned of record as follows: (i) 194,606 shares by WCP III, (ii) 1,287,433 shares by Waud QP III, (iii) 596,913 shares by WCP FIF III and (iv) 219,756 shares by Waud Affiliates III. F7 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document
September 12, 2016 Filed Sep 14, 2016 21:05 UTC	Acadia Healthcare Company, Inc. ACHC · Entity 4312	SaleCommon Stock, par value $0.01 per share	26,679	$51.77	$1,381,171.83	Disclosure SEC source: 0000899243-16-029008 · doc4.xml · nonDerivative · entry 1 WAUD CAPITAL PARTNERS III, L.L.C. · CIK 0001532461 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT III, L.P. · CIK 0001532462 · 10% owner WAUD CAPITAL PARTNERS III, L.P. · CIK 0001487016 · 10% owner WAUD CAPITAL PARTNERS QP III, L.P. · CIK 0001487019 · 10% owner WCP FIF III (ACADIA), L.P. · CIK 0001532465 · 10% owner WAUD CAPITAL AFFILIATES III, L.L.C. · CIK 0001532468 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 2,301,983 F1 · shares: Represents shares sold in market transactions under Rule 144 as follows: (i) 665 shares by Waud Capital Partners III, L.P. ("WCP III"), (ii) 14,664 shares by Waud Capital Partners QP III, L.P. ("Waud QP III"), (iii) 8,296 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III") and (iv) 3,054 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.58 to $52.01, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners III, L.L.C. ("Waud III LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management III, L.P. ("WCPM III"). Waud III LLC is the general partner of WCPM III. WCPM III is the general partner of WCP III, Waud QP III and WCP FIF III and the manager of Waud Affiliates III. As a result, each of Mr. Waud, Waud III LLC and WCPM III may be deemed to share beneficial ownership of the reported shares. F7 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document
September 09, 2016 Filed Sep 13, 2016 18:55 UTC	Acadia Healthcare Company, Inc. ACHC · Entity 4312	OtherCommon Stock, par value $0.01 per share	126,359	$0.00	$0.00	Disclosure SEC source: 0000899243-16-028906 · doc4.xml · nonDerivative · entry 1 WAUD CAPITAL PARTNERS III, L.L.C. · CIK 0001532461 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT III, L.P. · CIK 0001532462 · 10% owner WAUD CAPITAL PARTNERS III, L.P. · CIK 0001487016 · 10% owner WAUD CAPITAL PARTNERS QP III, L.P. · CIK 0001487019 · 10% owner WCP FIF III (ACADIA), L.P. · CIK 0001532465 · 10% owner WAUD CAPITAL AFFILIATES III, L.L.C. · CIK 0001532468 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 2,328,662 F1 · kind: Represents pro rata in-kind distributions for no consideration to certain of the limited partners of the following Reporting Persons: (i) 48,921 shares by Waud Capital Partners III, L.P. ("WCP III") and (ii) 77,438 shares by Waud Capital Partners QP III, L.P. ("Waud QP III"). F1 · shares: Represents pro rata in-kind distributions for no consideration to certain of the limited partners of the following Reporting Persons: (i) 48,921 shares by Waud Capital Partners III, L.P. ("WCP III") and (ii) 77,438 shares by Waud Capital Partners QP III, L.P. ("Waud QP III"). F2 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners III, L.L.C. ("Waud III LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management III, L.P. ("WCPM III"). Waud III LLC is the general partner of WCPM III. WCPM III is the general partner of WCP III, Waud QP III and WCP FIF III (Acadia), L.P. ("WCP FIF III") and the manager of Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"). As a result, each of Mr. Waud, Waud III LLC and WCPM III may be deemed to share beneficial ownership of the reported shares. F3 · ownership.nature: The reported shares are owned of record as follows: (i) 195,353 shares by WCP III, (ii) 1,303,897 shares by Waud QP III, (iii) 606,228 shares by WCP FIF III and (iv) 223,184 shares by Waud Affiliates III. F4 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.